Literature DB >> 19828166

Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study.

Enzo Ballotta1, Mario Gruppo, Franco Mazzalai, Giuseppe Da Giau.   

Abstract

BACKGROUND: Only a few operative or interventional studies have addressed the issue of isolated arterial occlusive disease at the femoral bifurcation, the early and late results reportedly being favorable in the former, controversial in the latter. The purpose of this study was to analyze the peri-operative (30-day) and long-term outcomes of isolated surgical endarterectomy in patients with occlusive disease at the common femoral artery (CFA), providing a baseline for comparison with emerging endovascular procedures.
METHODS: Over an 8-year period, all consecutive patients referred to our institution for claudication, rest pain, nonhealing ulcer(s), or minor tissue loss, with imaging findings of CFA occlusive disease (isolated or with additional infrainguinal lesions in the ipsilateral limb) amenable to endarterectomy of the CFA (isolated or combined with a profundoplasty or with the endarterectomy of the superficial or deep femoral artery first tract, not >1 cm long) were enrolled in the study. We excluded all patients with major tissue loss for which a contemporary infrainguinal revascularization was performed because treating the inflow disease alone would not be sufficient to heal the ischemic wound(s) owing to the presence of concomitant femoral and/or distal lesions, inadequate collateralization, or poor runoff. Descriptive demographic data, risk factors, clinical manifestations, and operative details were recorded. Primary patency (PP), assisted PP (APP), and limb salvage (LS) rates, freedom from additional proximal or distal revascularization in the ipsilateral limb, and survival were assessed using Kaplan-Meier life tables. Univariate and multivariate analyses were performed to identify which factors could influence CFA segment patency or other parameters.
RESULTS: In all, 117 patients were enrolled and underwent 121 CFA endarterectomies, 60.3% for claudication and 39.7% for critical limb ischemia (CLI); 30 patients were excluded because they underwent a contemporary infrainguinal revascularization. All procedures were performed with patients under regional anesthesia and took an average operating time of 1.3 +/- 0.7 hours. There were no perioperative deaths or major complications, but 8 (6.6%) local complications. A complete follow-up (mean 4.2 years) was obtained in 111 patients (115 limbs). The 7-year PP, APP, and LS rates were 96%, 100%, and 100%, respectively; the 7-year rates of freedom from further revascularization and survival were 79% and 80%, respectively.
CONCLUSION: Operative endarterectomy in patients with claudication or CLI for occlusive CFA disease proved safe, effective, and durable, and should provide a baseline for comparison with endovascular treatment. Proponents of endovascular procedures as a routine alternative treatment option should bear this in mind. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19828166     DOI: 10.1016/j.surg.2009.08.004

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

1.  Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection infusion for chronic lower extremity ischemia: 3-year results.

Authors:  Hai Feng; Xue-ming Chen; Chen-yu Li; Ren-ming Zhu; Jie Fang; Tian-you Wang
Journal:  Chin J Integr Med       Date:  2012-04-11       Impact factor: 1.978

Review 2.  Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.

Authors:  Taisei Kobayashi; Sahil A Parikh; Jay Giri
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

3.  Endovascular treatment for unilateral chronic total occlusions of the iliac artery categorized as TASC II type D lesions.

Authors:  Naokazu Miyamoto; Ryota Kawasaki; Tetsuya Fukuda; Masato Yamaguchi; Kazuro Sugimura; Koji Sugimoto
Journal:  Surg Today       Date:  2014-04-05       Impact factor: 2.549

Review 4.  Hybrid Operations in Patients with Peripheral Arterial Disease.

Authors:  Atsubumi Murakami
Journal:  Ann Vasc Dis       Date:  2018-03-25

5.  The Advantage of Common Femoral Endarterectomy Alone or Combined with Endovascular Treatment.

Authors:  Jun Hyung Kim; Byung Jun So; Seung Jae Byun; Kyung Yun Kim
Journal:  Vasc Specialist Int       Date:  2018-09-30

6.  Systematic Review and Proportional Meta-Analysis of Endarterectomy and Endovascular Therapy with Routine or Selective Stenting for Common Femoral Artery Atherosclerotic Disease.

Authors:  Khalid Hamid Changal; Mubbasher Ameer Syed; Tawseef Dar; Muhammad Asif Mangi; Mujeeb Abdul Sheikh
Journal:  J Interv Cardiol       Date:  2019-04-14       Impact factor: 2.279

7.  Extracellular Matrix Patches for Endarterectomy Repair.

Authors:  Keith B Allen; Joshua D Adams; Stephen F Badylak; H Edward Garrett; Nicolas J Mouawad; Steven W Oweida; Manesh Parikshak; Parvez K Sultan
Journal:  Front Cardiovasc Med       Date:  2021-02-11

8.  SUPERA Stenting in the Common Femoral Artery: Early Experience and Practical Considerations.

Authors:  Mary Jiayi Tao; Akshat Gotra; Kong Teng Tan; Naomi Eisenberg; Graham Roche-Nagle; Sebastian Mafeld
Journal:  Vasc Endovascular Surg       Date:  2022-02-11       Impact factor: 1.089

Review 9.  An Overview of the Treatment of Symptomatic Common Femoral Artery Lesions with a Focus on Endovascular Therapy.

Authors:  Nicolas W Shammas; Amanda Abi Doumet; Rusina Karia; Rommy Khalafallah
Journal:  Vasc Health Risk Manag       Date:  2020-02-20

10.  Stent-Assisted Angioplasty (SAA) at the Level of the Common Femoral Artery Bifurcation: Long-Term Outcomes.

Authors:  H Stricker; L Spinedi; C Limoni; L Giovannacci
Journal:  Cardiovasc Intervent Radiol       Date:  2020-01-23       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.